Company / Income Tax
Biogen Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$263.6M
FY2025
5-year range
$52.5M / $632.8M
FY2021-FY2025
Trend
-3.7%
vs FY2024
Sector context
#13 of 202
Health Care
What the data says
Among 202 Health Care companies, Biogen is in the bottom 6% for income tax. Income Tax has fluctuated over the past 10 years, ranging from $53M in FY2021 to $2.5B in FY2017.
Based on SEC 10-K filings.
$264M in FY2025 with a 5-year CAGR of -23.3%. Top quartile in the Health Care sector.
Increased from $135M to $264M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -25.3%
- 5-Year CAGR
- -23.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 202This company $263.6M Sector average $119.7M
▼
+120.1% above sector average
Key checks
Key Insights
- 5-year CAGR of -23.3%, indicating a declining trend.
- In FY2025, income tax decreased 3.7% year-over-year.
- Ranks #13 out of 202 companies in the Health Care sector.
- Peak income tax was recorded in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $263.6M | -3.7% |
| FY2024 | $273.8M | +102.4% |
| FY2023 | $135.3M | -78.6% |
| FY2022 | $632.8M | +1105.3% |
| FY2021 | $52.5M | -94.7% |
| FY2020 | $992.3M | -14.3% |
| FY2019 | $1.2B | -18.8% |
| FY2018 | $1.4B | -42.0% |
| FY2017 | $2.5B | +98.7% |
| FY2016 | $1.2B | +6.5% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026